The overlap between IBS and IBD: what is it and what does it mean? - Wikidata - wikimedia - TriplyDB

The overlap between IBS and IBD: what is it and what does it mean?

The overlap between IBS and IBD: what is it and what does it mean?

http://www.wikidata.org/entity/Q38177849

about

Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?Biomarkers of Irritable Bowel Syndrome Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity.Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions.IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.Implementing a self-management strategy in inflammatory bowel disease (IBD): patient perceptions, clinical outcomes and the impact on service.Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

P2860

Q26765219-D5547688-EA58-4A1B-9F01-B1978A1F56B8 Q28069902-BFCDE5B9-2831-458A-A504-C925BBC245F3 Q28071496-49C90A61-1DA0-4153-824A-4E0FAFA7FCD8 Q35603014-8A563741-7ADD-4D6F-AFCD-C6E3A6FBF694 Q40830748-840DF541-8E8C-427B-A6A7-68E467F5F7B8 Q42385650-999897AC-AA59-4118-8654-D671FFE30345 Q47864147-574EDC15-6FE9-4B68-BBEC-43F8FECAF7E0 Q48039023-320F5C6A-768D-4CD7-B9B2-CFB82E8751E7 Q48620917-5682D029-ADD2-4CD5-ACB1-7A1C2DCF017F Q55266163-5224B404-CC3E-48E1-B342-040168F83968 Q55282548-38DC5492-5EF2-473E-8BD1-C84C135A592E

P2860

The overlap between IBS and IBD: what is it and what does it mean?

http://www.wikidata.org/entity/Q38177849

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The overlap between IBS and IBD: what is it and what does it mean?

@en

type

label

The overlap between IBS and IBD: what is it and what does it mean?

@en

prefLabel

The overlap between IBS and IBD: what is it and what does it mean?

@en

P1433

Q38177849-B6C77632-DC22-4FBA-BADA-2096A9EE9002

P1476

Q38177849-76F6F68E-1790-4F51-8175-2E809FD387CF

P2093

Q38177849-85A0F4AF-4D60-40E5-B3D4-B0DC3DFCCEDE

Q38177849-930963E4-1E81-422B-A1C8-333B8CC7B1C2

P2860

Q38177849-02A7ADF8-AF43-4285-8A31-2A82C758BCE8

Q38177849-09E5EE54-1692-4DE4-A3A8-F978B3223B09

Q38177849-1F73233E-D8A6-4313-82E9-4469DE3EAE28

Q38177849-2CC7D157-2DB1-40E4-ABF0-3C99161CB2E9

Q38177849-2D270FE4-7673-49F0-8AF4-EACBD3AFD147

Q38177849-3B6C56AC-DE98-47B2-BD5D-E95CB1CFB0E5

Q38177849-5CD7FEA4-63A0-4899-AE7B-1370F9EF35A3

Q38177849-6112FC7B-8213-40E1-974A-C9740532C8A8

Q38177849-6B33DA64-3F9C-42E1-B60D-3DD66C59B33A

Q38177849-6B38BF05-7F9D-4DFD-8F4C-B33F5C82AEA7

P304

Q38177849-26F1648D-4E75-419A-BE52-9F8F7884F8E9

P31

Q38177849-2AF49759-AD8A-4995-B0CE-C76D7B29D9B4

P356

Q38177849-FCCFC957-362B-4165-9653-56D0C59EFC6F

P433

Q38177849-A23B2D86-D3D8-4153-9C7D-B4A28E60F803

P478

Q38177849-2FE9B74C-F25A-4E6E-BBA5-61F237B4508A

P577

Q38177849-2568D30C-B433-4E9F-96C2-3BEAA30583D9

P698

Q38177849-45C64610-A121-4D9D-9E54-1172F8EA4690

P356

17474124.2014.876361

P1433

Expert Review of Gastroenterology & Hepatology

P1476

The overlap between IBS and IBD: what is it and what does it mean?

@en

P2093

Eamonn M M Quigley

http://www.w3.org/2001/XMLSchema#string

Vladimir Stanisic

http://www.w3.org/2001/XMLSchema#string

P2860

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics

Intestinal permeability defects: is it time to treat?

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17474124.2014.876361

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24417262

http://www.w3.org/2001/XMLSchema#string